ANTIGENICS, INC.
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 9.17TCr | ||||||
| 3.94TCr | ||||||
| 3.45TCr | ||||||
| 2.67TCr | ||||||
| 1.51TCr |
